Results 281 to 290 of about 340,068 (318)

Aplastic anemia: Pathophysiology.

Seminars in Hematology, 2022
Bone marrow failure (BMF) syndromes are a heterogeneous group of benign hematological conditions characterized by uni- or multi-lineage marrow and/or peripheral blood cytopenia(s), and can be classified in constitutional or acquired syndromes based on ...
V. Giudice, C. Selleri
semanticscholar   +4 more sources

Oxyphenbutazone and aplastic anemia [PDF]

open access: possibleThe American Journal of Medicine, 1972
Abstract Described here is a patient with rheumatoid arthritis in whom aplastic anemia developed while he was taking oxyphenbutazone. Although few cases of hematologic toxicity have been reported in association with this drug, the hazard is probably comparable to that with phenylbutazone.
Robert M. Pilewski   +3 more
openaire   +2 more sources

The Aplastic Anemias

Hospital Practice, 1980
Bone marrow transplantation and androgen therapy offer some hope of survival for patients with aplastic anemia, whether the disease is idiopathic or induced by drugs or toxins.
openaire   +3 more sources

CHLORAMPHENICOL AND APLASTIC ANEMIA

JAMA: The Journal of the American Medical Association, 1952
Since chloramphenicol is an efficient broad spectrum antibiotic that is widely used, the possibility that it may be the cause of hematological disorders is, naturally, a serious one. Recently, five cases of fatal aplastic anemia have come to our attention. In each instance, we believe chloramphenicol to be etiologically implicated. It is our purpose to
Jack J. Rheingold, Carroll L. Spurling
openaire   +3 more sources

Aplastic and Hypoplastic Anemia

Pediatric Clinics of North America, 1980
Aplastic anemia is an acquired or constitutional trilineage bone marrow failure with peripheral pancytopenia, evidence of cellular hypoplasia of marrow, and replacement of normal cellular elements by fat. In some cases the marrow may be hypoplastic and the peripheral cytopenia relatively mild.
David G. Nathan, Jeffrey M. Lipton
openaire   +3 more sources

Aplastic anemia

JAAPA : official journal of the American Academy of Physician Assistants
Aplastic anemia (AA) is an inherited, idiopathic, or acquired syndrome of bone marrow failure characterized by pancytopenia and ineffective hematopoiesis.
Alexis C. Geppner
semanticscholar   +1 more source

Acquired Aplastic Anemia

Annals of Internal Medicine, 1999
In aplastic anemia, hematopoiesis fails: Blood cell counts are extremely low, and the bone marrow appears empty. The pathophysiology of aplastic anemia is now believed to be immune-mediated, with active destruction of blood-forming cells by lymphocytes.
openaire   +5 more sources

Management of aplastic anemia after failure of frontline immunosuppression

Expert Review of Hematology, 2019
Introduction: About 60% of aplastic anemia (AA) patients are in need of further treatment after frontline standard immunosuppressive therapy (IST).
F. Pierri, C. Dufour
semanticscholar   +1 more source

Erythropoietin in aplastic anemia

Blut, 1979
The level of erythropoietin (Ep) was measured in sera and urine from aplastic anemia patients. Increased levels of Ep were demonstrated in sera from all 25 patients studied. An elevated level of Ep was found in the urine of 17 of 23 patients in whom the urine was tested. No correlation between blood hemoglobin and Ep level was observed.
L Biljanovic-Paunovic   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy